Search

Jianbin Wang

from Harleysville, PA
Age ~45
Get Report
Also known as:
Jian Bin Wang, Wang Jianbin
Related to:
Nadia J Wang, 41Baiqing Wang, 48Jinxin WangXiaoli Yang, 59Baiquing WangRandolph Wang, 55Heyang Wang, 50
Connected to:
Aaron Wang, 36Aijie Wang, 53Ailin Y Wang, 67Aiying Wang, 63Alex F Wang, 50Alexandra Wang, 50Alfred C Wang, 47Ally H Wang, 49Amerfil M Wang, 79Andreas Wang, 27

Jianbin Wang Phones & Addresses

  • Harleysville, PA
  • Lansdale, PA
  • Sunnyvale, CA
  • Palo Alto, CA
  • Mountain View, CA
  • Buffalo, NY
  • Clearwater, FL
  • Lewisburg, PA

Education

School / High School: Duke University School of Law

Ranks

Licence: New York - Currently registered Date: 2010

Professional Records

Lawyers & Attorneys

Jianbin Wang Photo 1

Jianbin Wang - Lawyer

View page
Address:
Linklaters LLP Beijing Office
(106) 535-0642 (Office)
Licenses:
New York - Currently registered 2010
Education:
Duke University School of Law

Publications

Us Patents

Modification Of Cxcr4 Using Engineered Zinc Finger Proteins

View page
US Patent:
20100291048, Nov 18, 2010
Filed:
Mar 18, 2010
Appl. No.:
12/661539
Inventors:
Michael C. Holmes - Oakland CA, US
Jeffrey C. Miller - San Leandro CA, US
Jianbin Wang - San Ramon CA, US
International Classification:
A61K 35/12
C07K 14/00
C07K 7/06
C07H 21/04
C12N 15/79
C12N 5/071
C12N 5/078
C12N 5/0783
C12N 5/0784
C12N 5/0786
US Classification:
424 9321, 530350, 530329, 536 231, 4353201, 435325, 435366, 435372, 4353723
Abstract:
Disclosed herein are methods and compositions for modulating activity of CXCR4 genes, for example using zinc finger transcription factors (ZF-TFs) or zinc finger nucleases (ZFNs) comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding ZF-TFs or ZFNs, vectors comprising polynucleotides encoding ZF-TFs or ZFNs and cells comprising polynucleotides encoding ZF-TFs or ZFNs and/or cells comprising ZF-TF or ZFNs are also provided.

Methods And Compositions For Inhibiting Viral Entry Into Cells

View page
US Patent:
20120093787, Apr 19, 2012
Filed:
Sep 26, 2011
Appl. No.:
13/245702
Inventors:
Michael C. HOLMES - Oakland CA, US
Jianbin WANG - San Ramon CA, US
International Classification:
A61K 35/12
A61P 31/18
A61P 31/12
C12N 5/10
C12N 15/85
US Classification:
424 9321, 435325, 435455
Abstract:
Disclosed herein are methods and compositions for inhibiting viral entry into cells.

Methods And Systems For Analysis Of Single Cells

View page
US Patent:
20130225435, Aug 29, 2013
Filed:
Jul 19, 2011
Appl. No.:
13/811065
Inventors:
Michael F. Clarke - Stanford CA, US
Stephen R. Quake - Stanford CA, US
Piero D. Dalerba - Palo Alto CA, US
Huiping Liu - Chicago IL, US
Anne A. Leyrat - San Carlos CA, US
Tomer Kalisky - Givat Shmuel, IL
Maximilian Diehn - Stanford CA, US
Michael Rothenberg - Menlo Park CA, US
Jianbin Wang - Millbrae CA, US
Neethan Lobo - San Francisco CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12N 15/10
US Classification:
506 9
Abstract:
Methods are provided for diagnosis and prognosis of disease by analyzing expression of a set of genes obtained from single cell analysis. Classification allows optimization of treatment, and determination of whether on whether to proceed with a specific therapy, and how to optimize dose, choice of treatment, and the like. Single cell analysis also provides for the identification and development of therapies which target mutations and/or pathways in disease-state cells.

Methods And Compositions For Targeted Single-Stranded Cleavage And Targeted Integration

View page
US Patent:
20100047805, Feb 25, 2010
Filed:
Aug 18, 2009
Appl. No.:
12/583329
Inventors:
Jianbin Wang - San Ramon CA, US
International Classification:
C12Q 1/68
C07K 14/00
C07H 21/00
C12N 5/071
C12N 15/66
US Classification:
435 6, 530400, 536 231, 4353723, 435455
Abstract:
Disclosed herein are methods and compositions for generating a single-stranded break in a target sequence, which facilitates targeted integration of one or more exogenous sequences.

Methods And Compositions For Targeted Single-Stranded Cleavage And Targeted Integration

View page
US Patent:
20220316016, Oct 6, 2022
Filed:
Oct 18, 2021
Appl. No.:
17/504298
Inventors:
- Brisbane CA, US
Jianbin Wang - Brisbane CA, US
International Classification:
C12Q 1/70
C12N 15/90
C12N 9/22
C12Q 1/689
Abstract:
Disclosed herein are methods and compositions for generating a single-stranded break in a target sequence, which facilitates targeted integration of one or more exogenous sequences.

Gene Regulation Via Conditional Nuclear Localization Of Gene Modulating Polypeptides

View page
US Patent:
20210070830, Mar 11, 2021
Filed:
Sep 18, 2020
Appl. No.:
17/025259
Inventors:
- Menlo Park CA, US
Jianbin WANG - San Ramon CA, US
International Classification:
C07K 14/705
C12N 5/0783
C12N 9/22
Abstract:
The present disclosure provides a system for regulating expression of a target polynucleotide in a cell. The system may comprise a chimeric polypeptide comprising a gene modulating polypeptide fused in-frame with a heterologous nuclear localization domain. The heterologous nuclear localization domain may be operable to translocate the chimeric polypeptide to a cell nucleus upon activation by an active cellular signaling pathway. The cellular signaling pathway may be inducible in response to an extracellular signal. In response to the extracellular signal, the chimeric polypeptide may localize to the cell nucleus and the gene modulating polypeptide may regulate expression of a target polynucleotide in the cell nucleus.

Compositions And Methods To Treat Herpes Simplex Virus Infections

View page
US Patent:
20190224284, Jul 25, 2019
Filed:
Sep 5, 2018
Appl. No.:
16/122559
Inventors:
- South San Francisco CA, US
Jianbin Wang - South San Francisco CA, US
International Classification:
A61K 38/46
A61K 9/08
C12N 9/16
A61K 9/00
Abstract:
Herpes simplex virus (HSV) including herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are a persistent cause of human disease with no known cure. Guided nuclease systems target specific regions of the HSV-1 and HSV-2 genomes, disrupting the virus' nucleic acid and rendering even latent viruses incapacitated.

Compositions And Methods For Cell Targeted Hpv Treatment

View page
US Patent:
20190201501, Jul 4, 2019
Filed:
Dec 18, 2018
Appl. No.:
16/224591
Inventors:
- South San Francisco CA, US
Jianbin Wang - South San Francisco CA, US
International Classification:
A61K 38/46
C12N 9/22
A61K 9/127
A61K 31/7105
Abstract:
The invention provides compositions and methods for treating human papillomavirus (HPV) infections using a targetable nuclease, which compositions and methods can be used to selectively target the HPV genome or selectively express the targetable nuclease within cells that infected by HPV. By selectively targeting cells infected by HPV, the HPV genome within infected cells, or both, the nuclease is able to cleave the HPV genome thereby inactivating it and rendering it inoperable, interfering with the virus's ability to propagate even where the virus is in a latent stage of infection. Since latent HPV can be cleaved and eradicated from the host cells, compositions and methods of the invention may be used to treat HPV infections and potentially prevent many of the adverse health consequences associated with the papillomavirus.

Isbn (Books And Publications)

Werbewirksam Handeln in Einer Fremden Kultur: Eine Untersuchung Interkultureller Unterschiede Zwischen Dem Deutschen Und Dem Chinesischen Werbenden Sprechen Aus ubersetzungswissenschaftlicher Sicht

View page
Author

Jianbin Wang

ISBN #

3631304137

Control profile
Jianbin Wang from Harleysville, PA, age ~45 Get Report